Orale Diabetestherapie: Welche Substanz ist wann indiziert?

Author: Hamann A.   Morcos M.   Nawroth P.  

Publisher: Springer Publishing Company

ISSN: 0020-9554

Source: Der Internist, Vol.45, Iss.12, 2004-12, pp. : 1356-1363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next